Abstract
Introduction: Preoperative technetium Tc 99m Sestamibi has become the gold standard for localization in primary hyperparathyroidism treated by minimally invasive parathyroidectomy; however, no large cohort studies from a single institution have been published to prove this model is effective. The goal of this study was to quantify how well Sestamibi scans predict findings upon surgical exploration and compared to final pathology. Methods: All patients >16 years, diagnosed with hyperparathyroidism, who underwent a Sestamibi scan interpreted by a single radiologist from 6-1-07 to 5-30-08, were abstracted from hospital databases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
